Blood -- High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia

Blood, Vol. 114, Issue 21, 4675-4686, November 19, 2009

High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia
Blood Herling et al. 114: 4675

Supplemental materials for: Herling et al

Files in this Data Supplement:

Table S1. Demographics of the BCR-stimulated 70 CLL case set and associations with clinical parameters and tumor features (PDF, 130 KB)